BioSpace News Archive

Business

Ambys Medicines Appoints Ronald Park, M.D., Chief Executive Officer

Ambys Medicines, a cell and gene therapy company focused on advancing novel treatments to restore and regenerate liver function, today announced the appointment of Ronald Park, M.D., as the company’s new Chief Executive Officer. Dr. Park also joins the Ambys board of directors.

June 1, 2021
·
3 min read
Genetown

Seres Therapeutics Announces FDA Clearance of IND for SER-155, an Investigational Microbiome Therapeutic for the Prevention of Antibiotic-Resistant Bacterial Infections and Graft-versus-Host Disease (GvHD)

– SER-155 aims to prevent mortality in immunocompromised patients due to gastrointestinal infections, bacteremia and GvHD – – In collaboration with Memorial Sloan Kettering Cancer Center, Seres will now advance SER-155 into a Phase 1b clinical study –

June 1, 2021
·
6 min read
Myovant Sciences to Present at Upcoming Investor Conferences - June 01, 2021

Myovant Sciences, a healthcare company focused on redefining care for women and for men, invites investors and the general public to listen to webcasts at the following investor conferences

June 1, 2021
·
2 min read
Biotech Bay

Napo EU S.p.A., Jaguar Health’s Italian Subsidiary, Provides Updates on Plans to Pursue Conditional Marketing Authorization in the EU

Napo EU S.p.A., the Italian subsidiary of Napo Pharmacuticals, Inc., which is a wholly owned subsidiary of Jaguar Health, Inc., provided updates on plans to pursue conditional marketing authorization from the European Medicines Agency for crofelemer, the Company’s novel proprietary drug.

June 1, 2021
·
9 min read
Splashblocker, LLC Awarded Breakthrough Technology Agreement with Premier, Inc.

Splashblocker, LLC has been awarded a group purchasing agreement with Premier, Inc. effective June 1, 2021.

June 1, 2021
·
2 min read
Menarini Announces New SEL24/MEN1703 Clinical Data from DIAMOND-01 Trial

The Menarini Group announced today that additional data have been generated on SEL24/MEN1703, a first-in-class, orally available, dual PIM/FLT3 inhibitor, as part of the DIAMOND-01 tria

June 1, 2021
·
4 min read
Pharm Country

MYOS CORP to Attend VMX In Person, Will Introduce Three Products, Two Clinical Studies, and Vet Advisory Board

MYOS CORP, a research-based advanced nutrition company with divisions that address both Human Nutrition and Animal Health, announced that it will be attending in-person the 2021 North American Veterinary Meeting & Expo being held June 5-9 in Orlando, FL.

June 1, 2021
·
5 min read
Biotech Bay

Introducing ScienceAffinity™: A Strategic and Creative Consultancy from MEDiSTRAVA Focusing on Science-Driven Brand Storytelling

ScienceAffinity™, a global strategic and creative consultancy established to put science at the heart of branded and unbranded storytelling for all commercial brands that promise health and wellness outcomes, was officially introduced today as part of the MEDiSTRAVA group from Huntsworth Health

June 1, 2021
·
4 min read
BioCapital

Personal Genome Diagnostics Launches elio™ plasma complete, a Kit Enabling Decentralized, Comprehensive Liquid Biopsy Analysis for Oncology Research Applications

Personal Genome Diagnostics Inc. (PGDx), a leader in cancer genomics, today announced the launch of elio™ (empowering local insight for oncology) plasma complete, a NGS kit solution for comprehensive blood-based genomic analysis

June 1, 2021
·
2 min read
Business

BIO-CAT Announces Partnership with Kerry for Global Distribution of OPTI-BIOME MB40® Probiotic

BIO-CAT, Inc. -- a Virginia-based biotech company specializing in breakthrough enzyme product development -- has announced a global partnership with Kerry, the Taste & Nutrition company and their BIO-CAT Microbials, LLC probiotic products division

June 1, 2021
·
3 min read